Inovalon

Discover an innovative webinar exploring real-world data analytics in life sciences initiatives, engaging with stakeholders effectively and demonstrating differentiated value in shifting healthcare landscapes. As the healthcare ecosystem continues to shift its focus from volume to value, life sciences organizations are uniquely positioned to advance healthcare quality and outcomes by demonstrating the benefits their medicines bring to customers across the ecosystem. By combining the industry’s largest primary source claims dataset — Inovalon real-world data — with innovative analytics strategies, life sciences organizations can better understand patient populations across clinical, economic and social risk factors and effectively partner with payers and providers to improve population health outcomes via above-brand initiatives. Join Mark Rodgers, Associate Vice President of Commercial Analytics, Inovalon, as he shares strategies and tools to meaningfully engage with customers above the brand, identify opportunities to improve health outcomes and demonstrate differentiated value. Keywords: Real-World Data, Data Analytics, Data Strategy, Data Science, Commercialization/HEOR/Market Access

Discover an informative webinar delving into the use of real-world data analytics solutions to promote diversity, equity and inclusion (DEI) in clinical trials. The healthcare industry is currently facing significant challenges in designing clinical trials, particularly those related to accessibility and inclusivity. One of the most pressing issues is the recruitment of a diverse participant pool, which directly impacts the generalizability of findings and raises concerns regarding the applicability of results. This challenge is compounded by the fact that the inclusion of accessibility considerations in the design of trials can be complex, given the array of factors such as location, transportation and language barriers that may limit participation and skew results. In addition, a persistent challenge for clinical trial teams is to balance the need for informed consent with addressing potential coercion and ensuring cultural sensitivity.